The 8 isoform of protein kinase C is phosphorylated on tyrosine in response to antigen activation of the high-affinity receptor for immunoglobulin E. While protein kinase C-6 associates with and phosphorylates this receptor, immunoprecipitation of the receptor revealed that little, if any, tyrosine-phosphorylated protein kinase C-S is receptor associated. In vitro kinase assays with immunoprecipitated tyrosine-phosphorylated protein kinase C-S showed that the modified enzyme had diminished activity toward the receptor y-chain peptide as a substrate but not toward histones or myelin basic protein peptide. We propose a model in which the tyrosine phosphorylation of protein kinase C-S regulates the kinase specificity toward a given substrate. This may represent a general mechanism by which in vivo protein kinase activities are regulated in response to external stimuli.
ciated. In vitro kinase assays with immunoprecipitated tyrosine-phosphorylated protein kinase C-S showed that the modified enzyme had diminished activity toward the receptor y-chain peptide as a substrate but not toward histones or myelin basic protein peptide. We propose a model in which the tyrosine phosphorylation of protein kinase C-S regulates the kinase specificity toward a given substrate. This may represent a general mechanism by which in vivo protein kinase activities are regulated in response to external stimuli.
The activation of the mucosal mast cell model, rat basophilic leukemia (RBL) cells, by the interaction of antigen with cell-bound immunoglobulin E (IgE) initiates the rapid translocation and increased activity of protein kinase C (PKC) (1, 2) . This PKC activation is critical to the effector function of the mast cell, namely exocytosis of mediators of the allergic response (3, 4) . Protein kinase C-8 associates with and phosphorylates the high-affinity receptor for IgE FcsRI (5) on these cells, while other PKC isozymes regulate phosphoinositide hydrolysis (6) and induce protooncogene expression (7) .
Recent studies have begun to suggest that PKC may regulate tyrosine kinases and is itself regulated by phosphorylation interactions with these kinases (8) (9) (10) . Yao et al. (10) have shown a PKC-mediated inactivation of Bruton tyrosine kinase (BTK), an enzyme mutated in chromosome X-linked agammaglobulinemia patients. Moreover, BTK was found to associate with the f3I isoform of PKC in mast cells. Phosphorylation of serine/threonine kinases by tyrosine kinase activity has also been described (9, 11) . Denning et al. (9) showed that PKC-8 was tyrosine phosphorylated in cells expressing oncogenic ras. Li et al. (12) reported that 12-O-tetradecanoylphorbol 13-acetate (TPA) treatment of PKC-8 transfectants also led to tyrosine phosphorylation of this isozyme. More recent evidence from the latter group suggests that the tyrosine phosphorylation of PKC-8 can occur in response to platelet-derived growth factor receptor stimulation in PKC-8 transfected cells (13) . Collectively, the latter studies document the phosphorylation of a serine/threonine kinase by a tyrosine kinase activity in response to a stimulus, although the physiological significance of tyrosine phosphorylation of PKC-8 is unclear.
In the present study, we investigate whether tyrosine phosphorylation of PKC-8 occurs in response to FceRI aggregation and whether the tyrosine-phosphorylated form of PKC-8 is preferentially receptor associated. We also analyze the effect of tyrosine phosphorylation on the activity of PKC-8 toward various substrates, including the FcsRI y chain.
MATERIALS AND METHODS
Cell Cultures and Activation. The RBL-2H3 subline of RBL cells were cultured in monolayers in stationary flasks as described (14) . Cells (5 x 106 cells per ml) were sensitized with dinitrophenyl-specific mouse monoclonal IgE and activated with 2,4-dinitrophenylated-bovine serum albumin (DNP-BSA) as described (5) . Activation was for 1 min or for indicated times in medium or, for kinetic studies, in cell buffer without phosphatase inhibitors and EDTA (15) .
Cell Fractionation and Solubilization. After stimulation, cells (2 x 107 cells per ml) were resuspended in a cell buffer (15) modified by the addition of 1 mM Na3VO4/5 mM Na4P207/7 mM EDTA and protease inhibitors. Cells were disrupted by sonification, and 80-90% of the plasma membrane was recovered in the pellet fraction (15) . Triton X-100 was added to the recovered soluble fraction to a final concentration of 0.5%. Membrane pellets were solubilized (16) by using an equal volume of 0.5% Triton X-100 containing phosphatase inhibitors, protease inhibitors, and EDTA as above to obtain a final cell equivalent concentration of 2 x 107 cells per ml. Equal volumes (0.5 ml) of membrane or cytosol lysates were used for immunoprecipitations or 4To whom reprint requests should be addressed.
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clonal antiserum to PKC-8 (Research & Diagnostic Antibodies) was used at a 1:25,000 dilution. Secondary antibody, visualization, and quantitation were as described (5 
RESULTS
Tyrosine Phosphorylation and Membrane Association of PKC-6 in Response to FceRI Aggregation. Immunoprecipitation of PKC-5 from lysates prepared from antigen-activated RBL-2H3 cells led to the identification of a tyrosinephosphorylated form of this isozyme (Fig. 1A) . Cell fractionation showed an average increase of 2-fold for PKC-8 in the nuclear-free pelleted membrane fraction and the presence of tyrosine-phosphorylated PKC-6 with this fraction and not with the soluble fraction (Fig. 1B) . The rate of phosphorylation was found to be rapid, with maximal phosphorylation occurring 30 sec after addition of antigen (Fig. 1C) . PKC-8 translocation also occurred rapidly and seemed to coincide with tyrosine phosphorylation (Fig. 1C) , suggesting a translocationdependent phosphorylation. Phosphorylation appeared to be regulated by a phosphatase, as subsequent dephosphorylation of the tyrosine phosphorylated PKC-8 was rapid. Approximately 80% of the phosphorylated PKC-8 was no longer detected after 3 min of activation, although no apparent decrease of PKC-8 in the membrane fraction was observed. Depending on the experiment, 10-40% of membraneassociated PKC-6 was tyrosine phosphorylated (compare Table 1 and Fig. 4A ).
Translocation Is Required for Tyrosine Phosphorylation of PKC-6 but Not Vice Versa. Various agents that promote or inhibit PKC activity by binding to PKC were tested for their ability to translocate PKC-8 or to induce tyrosine phosphorylation of this isozyme. As can be seen in Table 1 , agents that promoted translocation also induced tyrosine phosphorylation. One inhibitor of PKC, calphostin C, did not cause translocation and failed to induce tyrosine phosphorylation. In contrast, all agents which effectively caused translocation of PKC-8, although some of these inhibit PKC activity, led to tyrosine phosphorylation of approximately 10% of the membrane-associated isozyme. probed with anti-PY antibodies, then stripped of this antibody as described (5) . After being extensively washed, membranes were blocked as described (15) We investigated the possibility that translocation of PKC-8 requires tyrosine phosphorylation. Cells were incubated in the presence of 300 ,uM genistein, a concentration previously shown to effectively inhibit tyrosine phosphorylation in RBL-2H3 cells (21) . As shown in Table 2 , tyrosine phosphorylation of total cellular proteins in response to antigen activation was effectively inhibited (69% ± 7%) in the presence of genistein, as was the tyrosine phosphorylation of PKC-8 in response to antigen activation (53% ± 6%). Treatment of RBL-2H3 cells with PMA also induced tyrosine phosphorylation of PKC-8 (Table 1) , and this phosphorylation was inhibited by 68% ± 11% ( In these experiments, the noncovalent association of receptor subunits (a1py2) was maintained as described (5) , and the intact receptor was depleted from antigen-activated membrane fractions by immunoprecipitation with antibody to mouse IgE. Fig.  2 shows that these conditions led to greater than 90% depletion (Fig. 2, lane 3 vs. lane 4) . Moreover, no detectable tyrosine phosphorylation was present at the molecular weight of PKC-8 in the receptor immunoprecipitates (Fig. 2, lane 1) , although PKC-8 was present in these immunoprecipitates (Fig. 2) . We cannot exclude the possibility that small amounts of tyrosine-phosphorylated PKC-8, not detectable with anti-phosphotyrosine antibodies, might associate with the receptor. Nevertheless, the majority of the tyrosine-phosphorylated PKC-8 is not coimmunoprecipitated with the receptor (Fig. 2, lane 3) . Similar results were obtained when receptor immunoprecipitation was done with antibody directed to the FcsRI f3 chain (data not shown). Collectively, these experiments suggest that a significant amount (57% ± 8%) of the activated receptor is associated with PKC-8 since the depletion of PKC-8 from the membrane fraction by immunoprecipitation resulted in the coprecipitation of large amounts of phosphorylated ,B chain (Fig. 2, lane  4) . These findings provide further evidence for the association of PKC-8 with the activated receptor and suggest that the tyrosine-phosphorylated PKC-8 is not exclusively associated with receptor.
Tyrosine Phosphorylation Modifies the Substrate Recognition of PKC-S. In these experiments, we utilized an RBL cell line stably transfected with PKC-8 to increase the amount of tyrosine-phosphorylated PKC-8 present in immunoprecipitates. The amount of tyrosine-phosphorylated PKC-8 in this transfectant was -3-fold more than that in untransfected RBL cells. This correlated with a 3-to 5-fold increase of PKC-6 associated with the membrane fraction of the transfectant, although the relative amount of PKC-6 translocated in response to antigen activation did not differ significantly from that of untransfected RBL cells (48% vs. 51% respectively; compare Fig. 1B and Fig. 3B ). Partial purification of total PKC from nonactivated and activated cells revealed an increased activity (1.3-to 1.5-fold) toward MBP peptide due to cell activation (Fig. 3A) . Likewise, a 2.2-fold increase in the activity of PKC-8 toward MBP peptide was found in the membrane fraction after cell activation (Fig. 3C ). This was accompanied by a concomitant depletion of activity from the cytosol and therefore is likely to be a reflection of the 2-to 2.5-fold increase in membrane-associated PKC-8 (Fig. 3B) . When histone type IlIs was used as a substrate, the PKC-6 from the membrane fraction of activated cells also exhibited an increased activity toward this substrate (Fig. 3D) . In contrast, when a peptide encoding the entire cytoplasmic domain of the FcsRI y chain (5) was used as a substrate, most of the PKC-6 activity was found in the membrane fraction from nonactivated cells (Fig. 3E) . Activation of the cells resulted in greater than 60% inhibition of the PKC-8 activity towards the y peptide. Fig. 3F . The inhibition observed at 1 min of activation is partially reversed after 3 min of activation. This coincides with the loss of approximately 80% of the tyrosine-phosphorylated PKC-8 (Fig. 1C) .
To determine if the presence of tyrosine-phosphorylated PKC-6 in immunoprecipitates of PKC-8 was responsible for the inhibitory effect toward -y-peptide phosphorylation, tyrosine-phosphorylated PKC-8 was depleted from membrane lysates of activated cells, and the kinase activity of the remaining PKC-5 was compared with the total membrane-associated PKC-8 activity. Fig. 4A shows that in this representative experiment 36% ± 7% of the PKC-6 is tyrosine phosphorylated. While depletion of the tyrosine phosphorylated PKC-8 was not complete (73% ± 6%), the activity, normalized for the amount of PKC-8 present in the immunoprecipitates (Fig. 4B) , was found to be approximately 3-fold higher in the immunoprecipitate depleted of tyrosine-phosphorylated (Fig.  4C) . The activity toward histones was decreased in the immunodepleted samples (data not shown).
DISCUSSION
The principal findings of this study are as follows: (i) (5, 22) , although activation of the receptor causes a 2-to 3-fold increase in threonine phosphorylation of the 'y chain (5, 22) . This implies an active form of PKC-a that is sequestered in the membrane prior to cell activation. Activation of the receptor results in translocation of up to 40% of the cytosolic PKC-8 to the membrane (ref. 4 and this study). This translocation is a requirement for tyrosine phosphoryla- tion of PKC-6 suggesting: (i) that translocation brings PKC-6 in juxtaposition with a tyrosine kinase that phosphorylates it and (ii) that this tyrosine kinase must be active, localized in the membrane, and regulated since translocation and tyrosine phosphorylation of PKC-6 can occur in the absence of increased tyrosine phosphorylation of cellular substrate-i.e., in the presence of PMA. The tyrosine-phosphorylated PKC-8 does not actively phosphorylate the FcsRI -y chain although our studies suggest that interaction does occur (Fig. 4) . Nevertheless, the tyrosine-phosphorylated PKC-8 is active as determined by its ability to phosphorylate MBP peptide and histones, and therefore may target a substrate previously not recognized by the non-tyrosine-phosphorylated form of PKC-8. Our results advance the intriguing possibility that regulation of PKC isozyme substrate specificity in vivo is mediated by crosstalk with enzymes of the tyrosine kinase families.
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